Found: 51
Select item for more details and to access through your institution.
HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Oral Preexposure Prophylaxis Uptake and Discontinuation in the HIV Vaccine Trials Network 704/HIV Prevention Trials Network 085 Study: Implications for Biomedical Human Immunodeficiency Virus Prevention Trials.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 7, p. 1, doi. 10.1093/ofid/ofae387
- By:
- Publication type:
- Article
Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03154-6
- By:
- Publication type:
- Article
Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35768-3
- By:
- Publication type:
- Article
Human adenovirus-specific T cells modulate HIV-specific T cell responses to an Ad5-vectored HIV-1 vaccine.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 1, p. 359, doi. 10.1172/JCI60202
- By:
- Publication type:
- Article
Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP ® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 741, doi. 10.3390/vaccines8040741
- By:
- Publication type:
- Article
Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa.
- Published in:
- AIDS & Behavior, 2023, v. 27, n. 9, p. 3027, doi. 10.1007/s10461-023-04025-z
- By:
- Publication type:
- Article
Mobile Phone Questionnaires for Sexual Risk Data Collection Among Young Women in Soweto, South Africa.
- Published in:
- AIDS & Behavior, 2018, v. 22, n. 7, p. 2312, doi. 10.1007/s10461-018-2080-y
- By:
- Publication type:
- Article
Comparability and reproducibility of biomedical data.
- Published in:
- Briefings in Bioinformatics, 2013, v. 14, n. 4, p. 391, doi. 10.1093/bib/bbs078
- By:
- Publication type:
- Article
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-43384-y
- By:
- Publication type:
- Article
Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0136626
- By:
- Publication type:
- Article
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-γ Secretion with Increased HIV-1 Infection Risk: A Cohort-Based Modeling Study.
- Published in:
- PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0108631
- By:
- Publication type:
- Article
Pre-Existing Adenovirus Immunity Modifies a Complex Mixed Th1 and Th2 Cytokine Response to an Ad5/HIV-1 Vaccine Candidate in Humans.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018526
- By:
- Publication type:
- Article
Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories.
- Published in:
- PLoS ONE, 2010, v. 5, n. 12, p. 1, doi. 10.1371/journal.pone.0014330
- By:
- Publication type:
- Article
In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide.
- Published in:
- PLoS ONE, 2010, v. 5, n. 2, p. 1, doi. 10.1371/journal.pone.0009310
- By:
- Publication type:
- Article
Methods for the estimation of direct and indirect vaccination effects by combining data from individual‐ and cluster‐randomized trials.
- Published in:
- Statistics in Medicine, 2024, v. 43, n. 8, p. 1627, doi. 10.1002/sim.10030
- By:
- Publication type:
- Article
Reply to Richie and Villasante.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study).
- Published in:
- 2012
- By:
- Publication type:
- journal article
Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study).
- Published in:
- Journal of Infectious Diseases, 2012, v. 206, n. 2, p. 258
- By:
- Publication type:
- Article
Timing of Plasmid Cytokine (IL-2/Ig) Administration Affects HIV-1 Vaccine Immunogenicity in HIV-Seronegative Subjects.
- Published in:
- Journal of Infectious Diseases, 2011, v. 204, n. 10, p. 1541, doi. 10.1093/infdis/jir615
- By:
- Publication type:
- Article
A Trimeric, V2-Deleted HIV-1 Envelope Glycoprotein Vaccine Elicits Potent Neutralizing Antibodies but Limited Breadth of Neutralization in Human Volunteers.
- Published in:
- Journal of Infectious Diseases, 2011, v. 203, n. 8, p. 1165
- By:
- Publication type:
- Article
Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors.
- Published in:
- Urological Research, 2003, v. 30, n. 6, p. 387, doi. 10.1007/s00240-002-0284-z
- By:
- Publication type:
- Article
A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention.
- Published in:
- PLoS Computational Biology, 2022, v. 18, n. 4, p. 1, doi. 10.1371/journal.pcbi.1010003
- By:
- Publication type:
- Article
Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 1, p. e2251974, doi. 10.1001/jamanetworkopen.2022.51974
- By:
- Publication type:
- Article
A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231086
- By:
- Publication type:
- Article
Analysis of the Na,K-ATPase α- and β-subunit expression profiles of bladder cancer using tissue microarrays.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 8, p. 1859
- By:
- Publication type:
- Article
Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Early Pro-Inflammatory Signal and T-Cell Activation Associate With Vaccine-Induced Anti-Vaccinia Protective Neutralizing Antibodies.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.737487
- By:
- Publication type:
- Article
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 519, p. 1, doi. 10.1126/scitranslmed.aaw1673
- By:
- Publication type:
- Article
Combining Viral Genetics and Statistical Modeling to Improve HIV-1 Time-of-Infection Estimation towards Enhanced Vaccine Efficacy Assessment.
- Published in:
- Viruses (1999-4915), 2019, v. 11, n. 7, p. 607, doi. 10.3390/v11070607
- By:
- Publication type:
- Article
Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens.
- Published in:
- PLoS ONE, 2024, v. 19, n. 9, p. 1, doi. 10.1371/journal.pone.0310042
- By:
- Publication type:
- Article
High Asymptomatic Carriage With the Omicron Variant in South Africa.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e289, doi. 10.1093/cid/ciac237
- By:
- Publication type:
- Article
Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69007-w
- By:
- Publication type:
- Article
Achieving intracellular cytokine staining assay concordance on two continents to assess HIV vaccine‐induced T‐cell responses.
- Published in:
- Journal of Leukocyte Biology, 2022, v. 112, n. 5, p. 1167, doi. 10.1002/JLB.5MA0522-668R
- By:
- Publication type:
- Article
Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 1, p. 78, doi. 10.1093/cid/ciae081
- By:
- Publication type:
- Article
Comparing and combining data across multiple sources via integration of paired-sample data to correct for measurement error.
- Published in:
- Statistics in Medicine, 2012, v. 31, n. 28, p. 3748, doi. 10.1002/sim.5446
- By:
- Publication type:
- Article
The sexually driven epidemic in youths in China's southwestern border region was caused by dynamic emerging multiple recombinant HIV-1 strains.
- Published in:
- Scientific Reports, 2015, p. 11323, doi. 10.1038/srep11323
- By:
- Publication type:
- Article
REACTOGENICITY AMONG PEOPLE LIVING WITH HIV AFTER mRNA-1273 VACCINE IN UBUNTU STUDY.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 405
- By:
- Publication type:
- Article
Therapeutic prediction of HIV-1 DNA decay: a multicenter longitudinal cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Comparing and combining data from immune assays based on left‐censored multivariate normal model assuming common assay differences across settings.
- Published in:
- Statistics in Medicine, 2023, v. 42, n. 2, p. 164, doi. 10.1002/sim.9607
- By:
- Publication type:
- Article
Assessing pharmacokinetic marker correlates of outcome, with application to antibody prevention efficacy trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Power/sample size calculations for assessing correlates of risk in clinical efficacy trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Analysis of the HIV Vaccine Trials Network 702 Phase 2b-3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials.
- Published in:
- PLoS Computational Biology, 2020, v. 16, n. 2, p. 1, doi. 10.1371/journal.pcbi.1007626
- By:
- Publication type:
- Article
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats.
- Published in:
- Clinical Trials, 2022, v. 19, n. 6, p. 647, doi. 10.1177/17407745221110880
- By:
- Publication type:
- Article